Sotac Pharmaceuticals Ltd vs Vivanza Biosciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Sotac Pharmaceuticals Ltd is ₹ 112 as of 04 May 10:43 . The P/E Ratio of Sotac Pharmaceuticals Ltd changed from 31.3 on March 2024 to 16.4 on March 2025 . This represents a CAGR of -27.61% over 2 yearsThe P/E Ratio of Vivanza Biosciences Ltd changed from 687.4 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Sotac Pharmaceuticals Ltd changed from ₹ 133.71 crore on March 2024 to ₹ 131.22 crore on March 2025 . This represents a CAGR of -0.94% over 2 yearsThe Market Cap of Vivanza Biosciences Ltd changed from ₹ 52.24 crore on March 2021 to ₹ 7.96 crore on March 2025 . This represents a CAGR of -31.36% over 5 years The revenue of Sotac Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Vivanza Biosciences Ltd for the Dec '25 is ₹ 45.33 crore as compare to the Sep '25 revenue of ₹ 55.37 crore. This represent the decline of -18.13% The ebitda of Sotac Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Vivanza Biosciences Ltd for the Dec '25 is ₹ 0.29 crore as compare to the Sep '25 ebitda of ₹ 0.61 crore. This represent the decline of -52.46% The net profit of Sotac Pharmaceuticals Ltd changed from ₹ 1.35 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The net profit of Vivanza Biosciences Ltd changed from ₹ 0.27 crore to ₹ 0.2 crore over 7 quarters. This represents a CAGR of -15.76% The Dividend Payout of Sotac Pharmaceuticals Ltd changed from 13.94 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Vivanza Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of 'M/s Sotac Pharmaceuticals', pursuant to a Deed of Partnership dated October 28, 2015.
Thereafter 'M/s.
Sotac Pharmaceuticals' was converted from Partnership Firm to a Private Limited Company in the name of 'Sotac Pharmaceuticals Private Limited' dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat.
Later on, Company converted into a Public Limited Company and the name of Company was changed to 'Sotac Pharmaceuticals Limited' dated November 22, 2022 issued by Registrar of Companies, Ahmedabad. The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis.

About Vivanza Biosciences Ltd

Vivanza Biosciences Limited, formerly known as Ivee Injectaa Limited was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992.
Due to recessionary trends which lead to difficult business conditions in year 1999-2000, the parenteral industry suffered a setback and due to this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015. The Company is focused in commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines.
It is presently engaged in the business of Pharmaceutical Products. Head quartered in Gujarat, India, Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.

FAQs for the comparison of Sotac Pharmaceuticals Ltd and Vivanza Biosciences Ltd

Which company has a larger market capitalization, Sotac Pharmaceuticals Ltd or Vivanza Biosciences Ltd?

Market cap of Sotac Pharmaceuticals Ltd is 129 Cr while Market cap of Vivanza Biosciences Ltd is 8 Cr

What are the key factors driving the stock performance of Sotac Pharmaceuticals Ltd and Vivanza Biosciences Ltd?

The stock performance of Sotac Pharmaceuticals Ltd and Vivanza Biosciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sotac Pharmaceuticals Ltd and Vivanza Biosciences Ltd?

As of May 4, 2026, the Sotac Pharmaceuticals Ltd stock price is INR ₹117.0. On the other hand, Vivanza Biosciences Ltd stock price is INR ₹2.07.

How do dividend payouts of Sotac Pharmaceuticals Ltd and Vivanza Biosciences Ltd compare?

To compare the dividend payouts of Sotac Pharmaceuticals Ltd and Vivanza Biosciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.